Workflow
Shandong Kaisheng New Materials (301069)
icon
Search documents
淄股一周:30股飘红,未名医药涨幅23.29%
Qi Lu Wan Bao Wang· 2025-05-09 13:19
Market Performance - The Shanghai Composite Index and Shenzhen Component Index experienced declines of 0.30% and 0.69% respectively on May 5, 2025, while the ChiNext Index and STAR Market 50 fell by 0.87% and 1.96% respectively [1] - Among 33 A-share companies in Zibo, 30 saw an increase, 1 remained flat, and 2 declined during the same period [1] Notable Stock Movements - Weiming Pharmaceutical (002581) achieved a remarkable 23.29% increase over five days, leading the gains [1] - Yahua Electronics (301337) and Jincheng Pharmaceutical (300233) also saw significant increases of 17.30% and 11.31% respectively [1] - On May 7, PEEK material concept stocks surged, with Zhongxin Fluorine Materials (002915) hitting the daily limit for the sixth time in nine days, and Kaisheng New Materials (301069) rising by 2.29% with a trading volume of 4.02 billion yuan [1] Company Announcements - Kehui Co., Ltd. announced a share repurchase plan with a budget between 9 million and 16 million yuan, with a maximum repurchase price of 17 yuan per share, aimed at employee stock ownership plans [1] Financial Results - Furuida (600223) reported a revenue of 526 million yuan in its cosmetics segment for Q1 2025, with a gross margin of 61.06% [3] - Qichang Tenda (002408) achieved total revenue of 5.618 billion yuan in Q1 2025, a year-on-year increase of 2.53%, but saw a significant drop in net profit by 83.18% to 5.4007 million yuan [3] - Xinhua Medical (600587) reported a total revenue of 2.308 billion yuan, down 8.74% year-on-year, with a net profit decline of 23.97% to 160 million yuan [3] - Bohui Paper (600966) reported a total revenue of 4.564 billion yuan, a 3.77% increase year-on-year, but a net profit decline of 46.91% to 53.3737 million yuan [3] Market Capitalization - In terms of market capitalization, Yingke Medical (300677) led with 14.708 billion yuan, followed closely by Shandong Pharmaceutical Glass (600529) at 14.626 billion yuan, and Qichang Tenda (002408) at 12.963 billion yuan [4]
PEEK材料概念涨1.75%,主力资金净流入这些股
Group 1 - The PEEK materials concept increased by 1.75%, ranking first among concept sectors, with 15 stocks rising, including Kent Shares, New Han New Materials, and Zhongxin Fluorine Materials, which rose by 12.97%, 12.38%, and 5.24% respectively [1][2] - The concept sector experienced a net outflow of 254 million yuan, with 12 stocks receiving net inflows, led by New Han New Materials with a net inflow of 55.99 million yuan, followed by Kent Shares, Nanjing Julong, and Kaisheng New Materials [2][3] - The net inflow ratios for Kent Shares, New Han New Materials, and Kaisheng New Materials were 12.82%, 6.67%, and 4.93% respectively, indicating strong interest from main funds [3] Group 2 - The top gainers in the PEEK materials sector included Kent Shares and New Han New Materials, while the top losers were Shuanglin Shares, Tian Ci Materials, and Chaojie Shares, which fell by 2.58%, 2.05%, and 1.79% respectively [1][4] - The trading volume and turnover rates for leading stocks in the PEEK materials sector were significant, with New Han New Materials having a turnover rate of 29.71% and Kent Shares at 28.03% [3][4] - The overall market performance showed a mixed trend, with various sectors experiencing both gains and losses, highlighting the volatility in the current market environment [2][4]
2025固态电池十大添加剂企业排名
鑫椤锂电· 2025-04-24 07:51
Core Viewpoint - Solid-state battery additives are crucial materials for enhancing battery performance, such as ionic conductivity and interface stability, with a comprehensive ranking based on technology routes, production capacity, and market performance. Group 1: LiFSI (Lithium bis(fluorosulfonyl)imide) Sector - Ruifai New Materials ranks among the top three global LiFSI producers, with a production capacity exceeding 10,000 tons by 2025, suitable for high-voltage solid-state battery requirements. The purity reaches 99.9%, and costs are 15% lower than traditional lithium hexafluorophosphate. The company has supplied to CATL and BYD for solid-state battery projects [1]. - Limin Co., Ltd. has extended its technology through its subsidiary Zhuobang New Energy, ranking among the top three in LiFSI production capacity, suitable for high-safety scenarios like robotics and flying cars [2]. - The customer network of Limin Co., Ltd. includes leading battery companies such as CATL and Tesla, with overseas orders expected to grow by 85% in 2024 [3]. Group 2: Sulfide Electrolyte Precursors - Tianci Materials is the largest electrolyte liquid company globally, extending LiFSI technology to sulfide electrolyte precursors, with costs 44% lower than Japanese competitors. By 2025, LiFSI production capacity will expand to 20,000 tons, supporting sulfide all-solid-state battery production lines [5]. - Tianci Materials holds over 60% market share in the global sulfide precursor market, with a binding relationship with Yunnan Germanium for raw materials. The ionic conductivity of sulfide electrolytes reaches 10 mS/cm, with costs 40% lower than similar Japanese products [5]. - The market share of zirconium oxychloride exceeds 50%, compatible with both oxide and sulfide dual technology routes, with samples sent to leading companies like Qingtai Energy. By 2025, zirconium-based material production capacity will reach 20,000 tons, covering key raw material needs for electrolytes [5]. Group 3: Chlorosulfonic Acid (LiFSI Raw Material) - Shilong Industrial has a cost advantage, with chlorosulfonic acid production costs 20% lower than the industry average, having entered the supply chains of Tianci Materials and Ruifai New Materials [6]. Group 4: Other Key Additives - Longpan Technology and Aoke Co., Ltd. have achieved a production capacity of 5,000 tons/year for solvent-based additives for solid-state batteries, suitable for optimizing sulfide electrolyte interfaces [7]. Group 5: Potential Enterprises - Daoshi Technology is focusing on conductive agents (carbon nanotubes) and silicon-carbon negative electrode additives, catering to the high energy density requirements of solid-state batteries [8]. - Guanghua Technology is developing lithium salts (LiTFSI) and composite additives to enhance the cycle life of solid-state batteries [9]. Group 6: Industry Leaders - Kaisheng New Materials is the largest chlorosulfonic acid supplier globally, with a production capacity exceeding 100,000 tons/year and a market share over 40%. The purity reaches electronic grade (99.999%), suitable for solid-state battery electrolyte synthesis [12]. - The company possesses a technical barrier, being one of the few globally to master full-solid-state compatible additive technology, with a projected market share growth to 18% in 2024. Key clients include CATL and Tesla, with plans to double production capacity by 2025 [13].
华邦生命健康股份有限公司 关于非公开发行可交换公司债券发行完成的提示性公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002004 证券简称:华邦健康公告编号:2025025 华邦生命健康股份有限公司 2025年3月20日,公司获得深圳证券交易所出具的《关于华邦生命健康股份有限公司非公开发行科技创 新可交换公司债券符合深交所挂牌条件的无异议函》(深证函〔2025〕249号)。详见公司于2025年3月 21日在巨潮资讯网(http://www.cninfo.com.cn)等指定信息披露媒体上披露的《关于收到〈关于华邦生 命健康股份有限公司非公开行科技创新可交换公司债券符合深交所挂牌条件的无异议函〉的公告》(公 告编号:2025005)。 截至2025年4月22日,公司面向专业投资者非公开发行可交换公司债券已发行完成,本次可交换债券的 相关信息如下: 4、换股期:自本期可交换公司债券发行结束之日满6个月后的第一个交易日起至本期可交换公司债券到 期日前一交易日止。 特此公告。 华邦生命健康股份有限公司 董事会 2025年4月24日 关于非公开发行可交换公司债券发行完成的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 ...
凯盛新材(301069) - 关于控股股东非公开发行可交换公司债券发行完成的提示性公告
2025-04-23 08:06
关于控股股东非公开发行可交换公司债券发行完成的提示性公告 本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 山东凯盛新材料股份有限公司(以下简称"公司"或"本公司")于 2024 年 12 月 11 日在巨潮资讯网(http://www.cninfo.com.cn)等指定信息披露媒体 上发布了《关于公司控股股东拟发行可交换公司债券的公告》:控股股东华邦生 命健康股份有限公司(以下简称"华邦健康")拟以其直接持有本公司的部分 A 股股票为标的非公开发行可交换公司债券。 2025 年 3 月 20 日,华邦健康获得深圳证券交易所出具的《关于华邦生命健 康股份有限公司非公开发行科技创新可交换公司债券符合深交所挂牌条件的无 异议函》(深证函〔2025〕249 号)。 | 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-024 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 2025 年 4 月 22 日,公司收到控股股东华邦健康通知,华邦健康以其所持公 司部分 A 股股票 ...
凯盛新材(301069) - 2024年度权益分派实施公告
2025-04-21 12:34
| 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-022 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 2024 年度权益分派实施公告 本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 本公司 2024 年年度权益分派方案为:以公司现有总股本 420,641,138 股为基 数,向全体股东每 10 股派 0.500000 元人民币现金(含税;扣税后,通过深股通 持有股份的香港市场投资者、境外机构(含 QFII、RQFII)以及持有首发前限售 股的个人和证券投资基金每 10 股派 0.450000 元;持有首发后限售股、股权激励 限售股及无限售流通股的个人股息红利税实行差别化税率征收,本公司暂不扣缴 个人所得税,待个人转让股票时,根据其持股期限计算应纳税额【注】;持有首 发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红利税,对香 港投资者持有基金份额部分按 10%征收,对内地投资者持有基金份额部分实行差 别化税率征收)。 【注:根据先进先出的原则,以 ...
凯盛新材(301069) - 关于可转换公司债券转股价格调整的提示性公告
2025-04-21 12:33
本公司及董事会全体成员保证公告内容真实、准确和完整,并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 特别提示: | 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-023 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司 关于可转换公司债券转股价格调整的提示性公告 1、债券代码:123233 2、债券简称:凯盛转债 3、本次调整前"凯盛转债"转股价格:20.06 元/股 4、本次调整后"凯盛转债"转股价格:20.01 元/股 5、本次转股价格调整生效日期:2025 年 4 月 30 日(股利分配除权除息日) 一、可转换公司债券基本情况 根据中国证券监督管理委员会《关于同意山东凯盛新材料股份有限公司向不 特定对象发行可转换公司债券注册的批复》(证监许可〔2023〕1893 号),山 东凯盛新材料股份有限公司(以下简称"公司")获准向不特定对象发行可转换 公司债券 650.00 万张,每张面值为人民币 100.00 元,募集资金总额为 650,000,000.00 元。经深圳证券交易所同意,公司本次向不特定对象发行的可 ...
凯盛新材2025年一季度盈利增长但需警惕现金流及债务风险
Zheng Quan Zhi Xing· 2025-04-19 23:56
Overall Overview - Company achieved total operating revenue of 269 million yuan in Q1 2025, representing a year-on-year increase of 12.28% [1] - Net profit attributable to shareholders reached 30.67 million yuan, up 19.35% year-on-year [1] - Deducting non-recurring gains and losses, net profit was 27.69 million yuan, reflecting a year-on-year growth of 27.72% [1] Key Financial Indicators Analysis Profitability - Gross margin stood at 29.7%, an increase of 11.31% compared to the same period last year, indicating improved cost control [2] - Net margin was 11.38%, up 6.65% year-on-year, showing enhanced profitability [2] - Earnings per share were 0.07 yuan, a year-on-year increase of 19.31%, reflecting value appreciation for shareholders [2] Operational Efficiency - The ratio of three expenses (selling, administrative, and financial expenses) to revenue was 8.62%, a decrease of 15.52% from the previous year, indicating effective cost management [2] Asset and Liability Status - Cash and cash equivalents amounted to 465 million yuan, a year-on-year increase of 3.48%, indicating a solid cash reserve [2] - Accounts receivable reached 155 million yuan, a significant year-on-year increase of 47.59%, raising concerns about collection risks [2] - Interest-bearing debt totaled 521 million yuan, up 6.32% year-on-year, suggesting a need for attention to debt levels and interest burdens [2] - The ratio of interest-bearing debt to total assets was 21.61%, with interest-bearing debt amounting to 29.31% of the average operating cash flow over the past three years, indicating some debt risk [2] - Financial expenses accounted for 134.59% of the average operating cash flow over the past three years, further increasing the financial burden on the company [2] - The ratio of accounts receivable to profit reached 276.8%, necessitating caution regarding potential bad debt losses [2]
凯盛新材2025年一季报简析:营收净利润同比双双增长,应收账款上升
Zheng Quan Zhi Xing· 2025-04-19 22:25
Financial Performance - The company reported a total revenue of 269 million yuan for Q1 2025, representing a year-on-year increase of 12.28% [1] - The net profit attributable to shareholders reached 30.67 million yuan, up 19.35% year-on-year [1] - The gross margin improved to 29.7%, an increase of 11.31% compared to the previous year [1] - The net profit margin also increased to 11.38%, reflecting a 6.65% year-on-year growth [1] - The company's operating cash flow per share decreased significantly by 79.18% to 0.01 yuan [1] Accounts Receivable and Debt - Accounts receivable rose to 155 million yuan, with a year-on-year growth of 47.59% [1] - Interest-bearing liabilities increased to 521 million yuan, marking a 6.32% rise [1] - The company's debt ratio for interest-bearing assets reached 21.61% [3] Research and Development - The company increased its R&D investment to approximately 53.8 million yuan in 2024, up from 51.5 million yuan in 2023 [5] - Several R&D projects have made progress, including studies on high-selectivity reactions and production processes [5] Market Expectations - Analysts expect the company's performance in 2025 to reach 80 million yuan, with an average earnings per share of 0.19 yuan [3]
凯盛新材(301069) - 第三届监事会第二十七次会议决议公告
2025-04-18 09:00
| 证券代码:301069 | 证券简称:凯盛新材 公告编号:2025-020 | | --- | --- | | 债券代码:123233 | 债券简称:凯盛转债 | 山东凯盛新材料股份有限公司(以下简称"公司")第三届监事会第二十七 次会议通知于 2025 年 4 月 15 日以电子邮件的形式发出,2025 年 4 月 18 日通过 通讯表决的方式召开,公司 3 名监事都参加了本次会议,会议的通知及召开符合 《公司法》及《公司章程》的规定,合法有效。本次会议由监事会主席张善民先 生主持,经与会各位监事认真讨论研究,审议并通过了以下议案: (一)会议以 3 票赞成、0 票反对、0 票弃权的表决结果审议通过了《山 东凯盛新材料股份有限公司 2025 年第一季度报告》。 详见公司于同日在巨潮资讯网(www.cninfo.com.cn)披露的《山东凯盛新 材料股份有限公司 2025 年第一季度报告》。 (二)会议以 3 票赞成、0 票反对、0 票弃权的表决结果审议通过了《关 于对山东凯盛新材料股份有限公司 2025 年第一季度报告的审议意见的议案》。 经过对公司《2025 年第一季度报告》进行全面的审核后,监事会认 ...